Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Ehlermann

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
Journal of Cardiovascular Development and Disease|October 26, 2022
Frequency, Risk Factors, and Clinical Outcomes of Late-Onset Atrial Flutter in Patients after Heart TransplantationAnn-Kathrin Rahm, Susanne Reinhardt, Matthias Helmschrott, et al.
Basic Research in Cardiology|December 14, 2002
The small EF-hand Ca2+ binding protein S100A1 increases contractility and Ca2+ cycling in rat cardiac myocytesAndrew Remppis, Patrick Most, Eva Löffler, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 14, 2019
Clinical and genetic insights into non-compaction: a meta-analysis and systematic review on 7598 individualsElham Kayvanpour, Farbod Sedaghat-Hamedani, Weng-Tein Gi, et al.
Journal of Molecular Medicine (Berlin, Germany)|November 8, 2007
Incomplete nonsense-mediated decay of mutant lamin A/C mRNA provokes dilated cardiomyopathy and ventricular tachycardiaStephanie K Geiger, Harald Bär, Philipp Ehlermann, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 7, 2014
Gender aspects in clinical presentation and prognostication of chronic heart failure according to NT-proBNP and the Heart Failure Survival ScoreJennifer Franke, Andreas Lindmark, Matthias Hochadel, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 21, 2019
A novel risk score to predict survival in advanced heart failure due to cardiac amyloidosisMichael M Kreusser, Martin J Volz, Benjamin Knop, et al.
Basic Research in Cardiology|November 1, 2015
Evidence of autoantibodies against cardiac troponin I and sarcomeric myosin in peripartum cardiomyopathyArash Haghikia, Ziya Kaya, Johannes Schwab, et al.
Life (Basel, Switzerland)|December 24, 2021
Risk Factors, Treatment and Prognosis of Patients with Lung Cancer after Heart TransplantationKarsten M Heil, Matthias Helmschrott, Fabrice F Darche, et al.
ESC Heart Failure|August 28, 2021
Atrial fibrillation before heart transplantation is a risk factor for post-transplant atrial fibrillation and mortalityFabrice F Darche, Matthias Helmschrott, Ann-Kathrin Rahm, et al.
Frontiers in Cardiovascular Medicine|June 27, 2022
Pre-transplant Type 2 Diabetes Mellitus Is Associated With Higher Graft Failure and Increased 5-Year Mortality After Heart TransplantationRasmus Rivinius, Carolin Gralla, Matthias Helmschrott, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Journal of Cardiovascular Development and Disease|October 26, 2022
Frequency, Risk Factors, and Clinical Outcomes of Late-Onset Atrial Flutter in Patients after Heart TransplantationAnn-Kathrin Rahm, Susanne Reinhardt, Matthias Helmschrott, et al.
Basic Research in Cardiology|December 14, 2002
The small EF-hand Ca2+ binding protein S100A1 increases contractility and Ca2+ cycling in rat cardiac myocytesAndrew Remppis, Patrick Most, Eva Löffler, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 14, 2019
Clinical and genetic insights into non-compaction: a meta-analysis and systematic review on 7598 individualsElham Kayvanpour, Farbod Sedaghat-Hamedani, Weng-Tein Gi, et al.
Journal of Molecular Medicine (Berlin, Germany)|November 8, 2007
Incomplete nonsense-mediated decay of mutant lamin A/C mRNA provokes dilated cardiomyopathy and ventricular tachycardiaStephanie K Geiger, Harald Bär, Philipp Ehlermann, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 7, 2014
Gender aspects in clinical presentation and prognostication of chronic heart failure according to NT-proBNP and the Heart Failure Survival ScoreJennifer Franke, Andreas Lindmark, Matthias Hochadel, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 21, 2019
A novel risk score to predict survival in advanced heart failure due to cardiac amyloidosisMichael M Kreusser, Martin J Volz, Benjamin Knop, et al.
Basic Research in Cardiology|November 1, 2015
Evidence of autoantibodies against cardiac troponin I and sarcomeric myosin in peripartum cardiomyopathyArash Haghikia, Ziya Kaya, Johannes Schwab, et al.
Life (Basel, Switzerland)|December 24, 2021
Risk Factors, Treatment and Prognosis of Patients with Lung Cancer after Heart TransplantationKarsten M Heil, Matthias Helmschrott, Fabrice F Darche, et al.
ESC Heart Failure|August 28, 2021
Atrial fibrillation before heart transplantation is a risk factor for post-transplant atrial fibrillation and mortalityFabrice F Darche, Matthias Helmschrott, Ann-Kathrin Rahm, et al.
Frontiers in Cardiovascular Medicine|June 27, 2022
Pre-transplant Type 2 Diabetes Mellitus Is Associated With Higher Graft Failure and Increased 5-Year Mortality After Heart TransplantationRasmus Rivinius, Carolin Gralla, Matthias Helmschrott, et al.
Pageof 9